News 08.07.2023 A surprising new role for a major immune regulator Better known as a cellular sentry, STING is also an ion channel that influences an array of immune responses Blainey Lab Read more
News 04.18.2023 Lung cancer’s molecular features shed light on immunotherapy response By integrating clinical, genetic, and other data from patients with lung cancer, researchers identify biological factors that could help predict treatment outcomes. Cancer Program Cancer News and Media Read more
News 05.06.2022 Exploring autoimmunity's regulatory roots Using a pair of high-throughput approaches, researchers sift genome-wide data for key non-coding variants influencing immune function. Cell Circuits Program Immunological Disease Connecting variants to functions Read more
News 08.31.2021 Researchers discover immune cell “hubs” hiding in tumors New study hints that colorectal tumors containing these immune hubs might be more likely to respond to existing immunotherapies. Cell Circuits Program Klarman Cell Observatory Cancer Single cell genomics Aviv Regev Read more
News 06.01.2021 Researchers identify potential new targets for next-generation COVID-19 vaccines Peptides encoded by unexplored regions of the SARS-CoV-2 genome provoke strong immune responses compared to other known peptides. Coronavirus Read more
News 05.04.2021 Researchers identify protein “signature” of severe COVID-19 Findings could help researchers identify mechanisms that cause severe disease Cell Circuits Program Coronavirus Read more
Blog 02.18.2021 #WhyIScience Q&A: How a physician-scientist’s clinical experience shapes his infectious disease research Research fellow Pierre Ankomah discusses what brought him to the United States and the mentors who helped him along the way. Infectious Disease and Microbiome Single cell genomics Gene-Expression Profiling Single Cell Read more
News 12.16.2019 New tool could help researchers design better cancer vaccines A computational model could improve the selection of tumor antigens for personalized cancer vaccines that are now in early-stage clinical trials. Cancer Program Cell Circuits Program Proteomics Platform Cancer Mass Spectrometry Read more
News 02.01.2019 New microfluidics platform separates cell types for RNA profiling Prototype technology demonstrates a more automated, efficient, and scalable workflow to analyze cells by type Blainey Lab Single cell genomics News and Media Read more
News 11.01.2018 Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma Study may help predict patient response, reduce treatment resistance Cancer Program Cell Circuits Program Cancer Single Cell News and Media Read more